Calliditas Therapeutics AB ( CALT) - Key Metrics
Stock symbol CALT is outdated, potentially delisted? Maybe it is available on other exchange?
CALT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $10.43 | -$0.88 | -$0.13 | -$0.13 |
| 2024Q1 | $11.01 | -$9.17 | -$7.39 | -$7.39 |
| 2023Q4 | $8.41 | -$0.34 | $0.43 | $0.19 |
| 2023Q3 | $5.49 | -$3.14 | -$1.17 | -$1.17 |
| 2023Q2 | $5.02 | -$1.71 | -$3.04 | -$3.04 |
CALT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -115.80 |
| 2024Q1 | ? | -6.17 |
| 2023Q4 | ? | -189.36 |
| 2023Q3 | ? | -15.89 |
| 2023Q2 | ? | -24.93 |
CALT
Price: $40
52 week price:
Earnings Per Share: -1.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Sweden
Volume: 12700
Market Capitalization: 1.1 billion